the Bispecific PSMAxCD3 Antibody CC-1 in Patients With Castration Resistant Prostate Carcinoma (clinicaltrials.gov) - Nov 29, 2023 - P1 | N=86 | Recruiting | Sponsor: University Hospital Tuebingen | Trial completion date: Aug 2023 ➔ Dec 2024 | Trial primary completion date: Mar 2023 ➔ Dec 2024
Trial completion date • Trial primary completion date • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
|